Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
Fernandes
Caraciolo J
CJ
Horst
David A
DA
O'Donovan
Donough J
DJ
D015331:Cohort Studies; D003422:Critical Care; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal; D008297:Male; D009305:Nasopharynx / Q000187:drug effects*; D011322:Primary Prevention / Q000379:methods; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000517:prevention & control*; D018570:Risk Assessment; D015996:Survival Rate; D016896:Treatment Outcome
D011663:Pulmonary Surfactants